Related Experiment Video
Updated: Nov 6, 2025

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
JD419, a Staphylococcus aureus Phage With a Unique Morphology and Broad Host Range
Tingting Feng1, Sebastian Leptihn2, Ke Dong3,4
1Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
A novel bacteriophage, JD219, effectively targets multidrug-resistant Staphylococcus aureus, including MRSA strains. Its genome lacks virulence genes, and it maintains stability under physiological conditions, showing therapeutic potential.
Area of Science:
- Microbiology
- Bacteriophage Research
- Antimicrobial Resistance
Background:
- Multidrug-resistant bacteria, particularly methicillin and vancomycin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat due to limited effective antibiotic options.
- Bacteriophage therapy is emerging as a promising alternative to combat these infections.
Purpose of the Study:
- To isolate and characterize a novel bacteriophage with broad-spectrum activity against Staphylococcus aureus.
- To evaluate the safety and stability of the isolated phage for potential therapeutic applications.
Main Methods:
- Isolation and characterization of bacteriophage JD219 from clinical samples.
- Determination of host range against 138 clinical Staphylococcus aureus strains, including MRSA.
- Assessment of phage stability at various pH and temperature conditions.
- Whole-genome sequencing and bioinformatic analysis to identify virulence or antibiotic resistance genes.
Main Results:
- Bacteriophage JD219 demonstrated a broad host range, infecting 61 out of 138 clinical Staphylococcus aureus strains, including MRSA.
- The phage exhibited unique morphology with an elongated capsid and flexible tail.
- JD219 remained infectious within a physiological pH range (6.0-8.0) and temperatures below 50°C.
- Genome sequencing revealed a 45,509 bp genome with 65 ORFs, none homologous to known virulence or antibiotic resistance genes, indicating it is a temperate phage.
Conclusions:
- Bacteriophage JD219 is a promising candidate for phage therapy against multidrug-resistant Staphylococcus aureus infections.
- Its genetic stability and lack of virulence factors, combined with broad host activity, support its therapeutic potential.
- Further genetic engineering could optimize JD219 for enhanced therapeutic efficacy by preventing lysogeny.
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Other Unique Bacteria
Bacterial Phylum Spirochaetes

